Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Contrasts in colorectal cancer incidence and mortality in screening trials of sigmoidoscopy versus colonoscopy (NordICC). 40971678 Meester RGS, Miller EA, Pinsky PF, Schoen RE, Ladabaum U J Natl Cancer Inst 2025 PLCO
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing. 40965920 Pickersgill NA, Peré MM, Vertosick EA, Nalavenkata S, Vieira Lima Aguiar Melão B, Vickers AJ, Lilja H, Eastham JA, Carlsson SV JAMA Oncol 2025 PLCO
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. 40965868 Meng Y, Wu F, Kwak S, Wang C, Usyk M, Freedman ND, Huang WY, Um CY, Gonda TA, Oberstein PE, Li H, Hayes RB, Ahn J JAMA Oncol 2025 PLCO
Metabolomic Biomarkers and Signature of Ultra-processed Foods Intake and Cardiovascular Morbidity and Mortality. 40950491 Wang L, Yang J, Chen J, Rebholz CM, Shu XO, Shrubsole MJ, Gupta DK, Lipworth L, Ma S, Dai Q, Zheng W, Yu D medRxiv 2025 PLCO
Challenging the Status Quo Regarding the Benefit of Chest Radiographic Screening. 40936165 Yankelevitz DF, Yip R, Henschke CI J Thorac Imaging 2025 PLCO
Ten-Year Trends in Digital Rectal Exam Results and Prostate Cancer Detection: Insights from the PLCO Trial. 40910103 Guan K, Dahman B, Tan SH, Chen D, Waters AJ, Chesnut GT, Kern SQ, Ahmed AE Res Rep Urol 2025 PLCO
MIXED MODELING APPROACH FOR CHARACTERIZING THE GENETIC EFFECTS IN A LONGITUDINAL PHENOTYPE. 40893136 Zhang P, Albert PS, Hong HG Ann Appl Stat 2025 PLCO
Comparison of Underlying Risk of Developing and Dying from Lung Cancer in Screened Populations. 40912293 Rivera MP, Benefield T, Durham DD, Lund JL, Reuland DS, Cheung LC, Lane LM, Katki HA, Henderson LM Chest 2025 NLST
Higher insoluble fiber intake is associated with a lower risk of prostate cancer: results from the PLCO cohort. 38243202 Shen Y, Yuan Q, Shi M, Luo B BMC Public Health 2024 PLCO
Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study. 38241820 Yang Z, Zhang Y, Zhuo L, Sun K, Meng F, Zhou M, Sun J Eur J Cancer 2024 PLCO
Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial. 38289605 Robertson SE, Joyce NR, Steingrimsson JA, Stuart EA, Aberle DR, Gatsonis CA, Dahabreh IJ JAMA Netw Open 2024 NLST
Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial. 38216080 Potter AL, Senthil P, Keshwani A, McCleery S, Haridas C, Kumar A, Mathey-Andrews C, Martin LW, Yang CJ Ann Thorac Surg 2024 NLST
Enrichment of lung cancer computed tomography collections with AI-derived annotations. 38177130 Krishnaswamy D, Bontempi D, Thiriveedhi VK, Punzo D, Clunie D, Bridge CP, Aerts HJWL, Kikinis R, Fedorov A Sci Data 2024 NLST
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. 38171245 Lee O , Bazzi LA , Xu Y , Pearson E , Wang M , Hosseini O , Akasha AM , Choi JN , Karlan S , Pilewskie M , Kocherginsky M , Benante K , Helland T , Mellgren G , Dimond E , Perloff M , Heckman-Stoddard BM , Khan SA Biomed Pharmacother 2024 EPPT
Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. 38175578 León-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JF Clin Chem 2024 PLCO
Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO. 38332674 Murphy G , Freedman ND , Abnet CC , Albanes D , Cross AJ , Huang WY , Koshiol J , McGlynn K , Parisi D , Männistö S , Weinstein SJ , Waterboer T , Butt J Helicobacter 2024 PLCO
Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort. 38285606 Byrd DA , Zouiouich S , Karwa S , Li XS , Wang Z , Sampson JN , Loftfield E , Huang WY , Hazen SL , Sinha R Cancer 2024 PLCO
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. 38308339 Ünal P, Lu Y, Bueno-de-Mesquita B, van Eijck CHJ, Talar-Wojnarowska R, Szentesi A, Gazouli M, Kreivenaite E, Tavano F, Małecka-Wojciesko E, Erőss B, Oliverius M, Bunduc S, Nóbrega Aoki M, Vodickova L, Boggi U, Giaccherini M, Kondrackiene J, Chammas … Hum Genomics 2024 PLCO
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. 38280379 Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, Grossman SR, Lenz HJ, Setiawan VW, Le Marchand L, Huang BZ Cell Rep Med 2024 PLCO
Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis. 37860916 Zhong H, Liu S, Zhu J, Xu TH, Yu H, Wu L Int J Cancer 2024 PLCO